Αποτελέσματα Αναζήτησης
28 Αυγ 2024 · Bisphosphonates are often the first choice for osteoporosis treatment. These include: Alendronate (Fosamax), a weekly pill. Risedronate (Actonel, Atelvia), a weekly or monthly pill. Ibandronate, a monthly pill or quarterly intravenous (IV) infusion. Zoledronic acid (Reclast), an annual IV infusion.
- Exercising With Osteoporosis
Edward R. Laskowski, M.D.: The bent-over row is an exercise...
- Calcium
Your body needs calcium to build and maintain strong bones....
- Bone Health Tips
You're at greater risk of osteoporosis if you're a woman,...
- Bone Density Test
Confirm a diagnosis of osteoporosis; Monitor osteoporosis...
- Back Pain
The spine is a column of bones held together by muscles,...
- Anorexia Nervosa
Early treatment of eating disorders leads to the best...
- Exercising With Osteoporosis
This review focuses on the pathology, causes, risk factors, symptoms, prevalence data, symptomatic treatments, and new research aimed at possible preventions and/or treatments of mitochondrial diseases.
Strong clinical trial evidence supports the use of alendronate, risedronate, and ibandronate for preventing fractures in women with postmenopausal osteoporosis or osteopenia. 26,27 These agents have been shown to reduce vertebral and hip fractures by 50% to 60% in postmenopausal women. 28–30 Clinical trial evidence also supports the use of ...
1 Μαΐ 2019 · The women considered the effectiveness and adverse events equally, followed by the convenience of taking the drug and its effect on daily routine (less frequent dosing was preferred, the oral route was preferred, and the injectable route was preferred over oral if given less frequently).
Although the recent literature provides some guidance, this review further explores current recommendations in light of newer evidence to provide more clarity on prevention, screening, and management strategies for patients with osteoporosis in the primary care setting. Introduction.
24 Φεβ 2024 · Treatment. Treatment recommendations are often based on an estimate of your risk of breaking a bone in the next 10 years using information such as the bone density test. If your risk isn't high, treatment might not include medication and might focus instead on modifying risk factors for bone loss and falls.
Although no cure for mitochondrial disease currently exists, consensus-based clinical guidelines are available to help manage patients and, for some mitochondrial diseases, potential treatments are emerging. An increasing number of clinical trials are investigating new or repurposed small molecules and gene therapy.
